FindTrial
Sign In

Mycoplasma pneumoniae Infection: Symptoms, Drug Resistance, and Treatment Options

?Retrospective Study on Co-morbidity Characteristics, Drug Resistance, and Treatment Strategies of Mycoplasma pneumoniae Infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120515
Enrollment
Unknown
Registered
2026-03-16
Start date
2025-08-28
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae

Interventions

Hospitalized children with Mycoplasma pneumoniae infection:None

Sponsors

Shantou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: Mp-infected individuals have typical clinical manifestations and have been confirmed by serology or tNGS

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Imaging findings;Laboratory indicators (CRP, fever peak, antibody titer);Targeted next-generation sequencing results;Drug resistance genes;Treatment regimen and clinical outcomes;—

Countries

China

Contacts

Public ContactZhou Hachao

Shantou Central Hospital

379337076@qq.com+86 754 87777566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026